Table 1.
Comparison of nAMD patients and control group, with patients’ clinical characteristics.
| nAMD Group, n = 20 | Control Group, n = 20 | P value | |
|---|---|---|---|
| Age (years) | 77.5 ± 10.25 | 77.65 ± 8.68 | 0.578# |
| Sex (male/female) | 1:0.67 | 0.82:1 | 0.342§ |
| Eyes (n) | 20 | 20 | N/A |
| Type of choroidal neovascularization (n) | 16 type 1 4 type 2 |
N/A | N/A |
| Central Retinal Thickness day 0 (μm) | 306.45 ± 57.78 | N/A | N/A |
| Central Retinal Thickness after 3 treatments (μm) | 239.45 ± 33.85 | N/A | N/A |
| Neovascular lesion size (μm) | 1971.25 ± 1021.02 | N/A | N/A |
Age, retinal thickness and lesion size are expressed as mean ± standard deviation. N/A: not applicable. #Mann-Whitney U test. §Chi-squared test.